Christopher Gibson - 08 Jan 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
08 Jan 2025
Net transactions value
-$287,200
Form type
4
Filing time
13 Jan 2025, 17:26:03 UTC
Previous filing
06 Dec 2024
Next filing
05 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +20,000 +2.7% $0.000000 756,633 08 Jan 2025 Direct F1, F2
transaction RXRX Class A Common Stock Sale $146,200 -20,000 -2.6% $7.31 736,633 08 Jan 2025 Direct F2
transaction RXRX Class A Common Stock Conversion of derivative security $0 +20,000 +2.7% $0.000000 756,633 10 Jan 2025 Direct F1, F2
transaction RXRX Class A Common Stock Sale $141,000 -20,000 -2.6% $7.05 736,633 10 Jan 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -20,000 -0.33% $0.000000 5,996,700 08 Jan 2025 Class A Common Stock 20,000 $0.000000 Direct F1, F2, F3
transaction RXRX Class B Common Stock Conversion of derivative security $0 -20,000 -0.33% $0.000000 5,976,700 10 Jan 2025 Class A Common Stock 20,000 $0.000000 Direct F1, F2, F3
holding RXRX Class B Common Stock 486,000 08 Jan 2025 Class A Common Stock 0 $0.000000 by LAHWRAN-3 LLC F3, F4
holding RXRX Class B Common Stock 388,000 08 Jan 2025 Class A Common Stock 0 $0.000000 by LAHWRAN-4 LLC F3, F5
holding RXRX Class B Common Stock 67,875 08 Jan 2025 Class A Common Stock 0 $0.000000 by Gibson Family Trust F3, F6
holding RXRX Stock Option (Right to Buy) 282,500 08 Jan 2025 Class A Common Stock 0 $2.48 Direct F7
holding RXRX Stock Option (Right to Buy) 813,600 08 Jan 2025 Class A Common Stock 0 $8.55 Direct F8
holding RXRX Stock Option (Right to Buy) 399,002 08 Jan 2025 Class A Common Stock 0 $11.40 Direct F9
holding RXRX Stock Option (Right to Buy) 5,436 08 Jan 2025 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 666,898 08 Jan 2025 Class A Common Stock 0 $10.09 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a disposition of shares by the Reporting Person.
F2 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2023.
F3 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F4 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F5 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F6 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F7 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F8 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F9 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F10 The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.